thomas george - university of florida...dr. george is board-certified in medical oncology and a...

1
UFHEALTH.ORG THOMAS J. GEORGE, MD, FACP Professor Director, Gastrointestinal Oncology Program Director, Experimental Therapeutics Incubator Associate Director for Clinical Research UF Department of Medicine and UF Health Cancer Center Research Interests: Cancer Genetics; Chemotherapy; DNA Damage & Repair; Drug Resistance; Gastro-Intestinal; Genetic Determinants of Cancer; Health Disparities; Immunotherapy; Metastasis; Targeted Cancer Therapy THOMAS J. GEORGE, MD, FACP , is the associate director for clinical research for UF Health Cancer Center, professor of medicine in the division of hematology & oncology and director of the UF Health Gastrointestinal Oncology Program. Dr. George began his career at UF in 2001 as chief medical resident in the department of medicine after completing his undergraduate and medical degrees at the University of Florida. His clinical and research areas of interest include experimental therapeutics, personalized oncology, immunotherapy as a cancer treatment, quality of life and decision making, and mentoring the next generation of cancer focused clinical investigators. His other research interests include cancer genetics; chemotherapy; DNA damage and repair; drug resistance; gastro- intestinal cancers; genetic determinants of cancer; health disparities; immunotherapy; metastasis; targeted cancer therapy; and the diagnosis and treatment of gastrointestinal malignancies, including: colorectal cancer, esophageal cancer, gastric cancer, liver cancer and pancreatic cancer. He serves as the principle investigator on dozens of clinical trials testing new cancer therapies for patients with GI cancers. These studies include, but are not limited to, those sponsored by the National Cancer Institute, the Pancreatic Cancer Action Network and the National Institutes of Health and the University of Florida. Dr. George also works in collaboration with behavioral scientists and communication specialists who are helping to break down the complex process of decision making in an attempt to determine how best to deliver treatment options and maximize quality of life when patients receive a cancer diagnosis or are choosing a cancer screening test. Dr. George is board-certified in medical oncology and a member of the medical honor society Alpha Omega Alpha, the American Society of Clinical Oncology, the American Association of Cancer Research and numerous clinical trial leadership groups. THOMAS GEORGE PS147679-4/10/19 (O) 352.265.0992 | (C) 352.339.6672 | (F) 352.265.0996 | tgeorge@ufl.edu

Upload: others

Post on 08-Aug-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: THOMAS GEORGE - University of Florida...Dr. George is board-certified in medical oncology and a member of the medical honor society Alpha Omega Alpha, the American Society of Clinical

U F H E A L T H . O R G

THOMAS J. GEORGE, MD, FACPProfessorDirector, Gastrointestinal Oncology ProgramDirector, Experimental Therapeutics IncubatorAssociate Director for Clinical ResearchUF Department of Medicine and UF Health Cancer Center

Research Interests: Cancer Genetics; Chemotherapy; DNA Damage & Repair; Drug Resistance; Gastro-Intestinal; Genetic Determinants of Cancer; Health Disparities; Immunotherapy; Metastasis; Targeted Cancer Therapy

THOMAS J. GEORGE, MD, FACP, is the associate director for clinical research for UF Health Cancer Center, professor of medicine in the division of hematology & oncology and director of the UF Health Gastrointestinal Oncology Program.

Dr. George began his career at UF in 2001 as chief medical resident in the department of medicine after completing his undergraduate and medical degrees at the University of Florida.

His clinical and research areas of interest include experimental therapeutics, personalized oncology, immunotherapy as a cancer treatment, quality of life and decision making, and mentoring the next generation of cancer focused clinical investigators. His other research interests include cancer genetics; chemotherapy; DNA damage and repair; drug resistance; gastro-intestinal cancers; genetic determinants of cancer; health disparities; immunotherapy; metastasis; targeted cancer therapy; and the diagnosis and treatment of gastrointestinal malignancies, including: colorectal cancer, esophageal cancer, gastric cancer, liver cancer and pancreatic cancer. He serves as the principle investigator on dozens of clinical trials testing new cancer therapies for patients with GI cancers. These studies include, but are not limited to, those sponsored by the National Cancer Institute, the Pancreatic Cancer Action Network and the National Institutes of Health and the University of Florida.

Dr. George also works in collaboration with behavioral scientists and communication specialists who are helping to break down the complex process of decision making in an attempt to determine how best to deliver treatment options and maximize quality of life when patients receive a cancer diagnosis or are choosing a cancer screening test.

Dr. George is board-certified in medical oncology and a member of the medical honor society Alpha Omega Alpha, the American Society of Clinical Oncology, the American Association of Cancer Research and numerous clinical trial leadership groups.

THOMAS GEORGE

PS147679-4/10/19

(O) 352.265.0992 | (C) 352.339.6672 | (F) 352.265.0996 | [email protected]